NCT07479628 2026-03-18
Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Shanghai Chest Hospital
Phase 2 Not yet recruiting
Clinical Trials
26 trialsNCT07132918 2026-03-11
HEARTS Trial for Thoracic Cancers
University of Wisconsin, Madison
Phase 2 Recruiting
NCT01025089 2026-01-07
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06838910 2025-12-01
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT06790706 2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2 Recruiting
NCT03463460 2025-08-24
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT06186726 2025-06-13
Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Shanghai Proton and Heavy Ion Center
Phase 2 Recruiting
NCT03921671 2024-05-29
RELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT04925947 2024-04-16
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
Weill Medical College of Cornell University
Phase 2 Terminated
NCT06019468 2023-09-06
Neoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT05816694 2023-04-18
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT03193437 2023-02-16
SELECT
Georgetown University
Phase 2 Terminated
NCT02307500 2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2 Completed
NCT05407649 2022-06-07
Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT03663764 2021-12-10
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Phase 2 Unknown
NCT03449173 2021-06-09
Style
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT00024076 2020-08-03
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT00198133 2019-07-22
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Indiana University
Phase 2 Completed
NCT01364727 2019-04-16
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
Phase 2 Completed
NCT02623127 2019-01-23
KOSMIC
Seoul National University Hospital
Phase 2 Completed
NCT03466827 2018-03-15
TET-SEL
Rigshospitalet, Denmark
Phase 2 Unknown
NCT00387868 2014-12-09
Preoperative Treatment of Patients With High Risk Thymoma
Valley Health System
Phase 2 Completed
NCT00369889 2014-06-03
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
Phase 2 Completed
NCT00818090 2013-04-12
Paclitaxel and Cisplatin for Thymic Neoplasm
Korean Cancer Study Group
Phase 2 Terminated
NCT00003662 2011-03-07
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
Roswell Park Cancer Institute
Phase 2 Completed